AP NEWS

Sleeping Aids Market by Offering, by Sleep Disorder, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013 - 2023 - ResearchAndMarkets.com

August 8, 2018

DUBLIN--(BUSINESS WIRE)--Aug 8, 2018--The “Sleeping Aids Market by Offering, by Sleep Disorder, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013 - 2023” report has been added to ResearchAndMarkets.com’s offering.

Global sleeping aids market is forecasted to attain revenue of $101.9 billion by 2023.

Growing prevalence of insomnia and obstructive sleep apnea (OSA) disorders, rising use of portable sleep apnea devices, increasing government support for start-up companies, growing healthcare facilities, surge in the demand for sleeping pills attributed to stressful modern lifestyle, and increasing geriatric population are the key factors driving the growth of the market.

Insights on market segments

Based on offering, the sleeping aids market has been categorized into mattress and pillows, sleep laboratory services, medication, sleep apnea devices and others. Sleep apnea devices are predicted to be the fastest growing product category in this market, witnessing CAGR of 7.4% during the forecast period. This growth is characterized by technology advancements and increasing number of OSA cases, globally.

The medication category is further classified into prescription drugs, over-the-counter drugs and herbal remedies. Among these, prescription drugs held the largest share in the sleeping aids medication market, with 65.7% share in 2017. Based on the sleep disorder, the sleeping aids market has been categorized into insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleep walking and others. Among these, insomnia held the largest share in this market, with 31.2% contribution in 2017, mainly due to rise in the prevalence of the number of insomnia cases over the years.

Some of the other players in sleeping aids industry are Sanofi, Merck KGaA, Koninklijke Philips N.V., Pfizer Inc., SleepMed Inc., Takeda Pharmaceutical Co. Ltd., Cadwell Laboratories Inc., Natus Medical Inc., and Compumedics Limited.

Key Topics Covered:

Chapter 1. Research Background

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Introduction

Chapter 5. Global Market Size And Forecast

Chapter 6. North America Market Size And Forecast

Chapter 7. Europe Market Size And Forecast

Chapter 8. Apac Market Size And Forecast

Chapter 9. Latam Market Size And Forecast

Chapter 10. Mea Market Size And Forecast

Chapter 11. Competitive Landscape

Chapter 12. Company Profiles

Sanofi Merck & Co. Inc. Koninklijke Philips N.V. Pfizer Inc. Sleepmed Inc. Cadwell Laboratories Inc. Natus Medical Incorporated Devilbiss Healthcare Llc Takeda Pharmaceutical Company Limited Compumedics Limited Tempur Sealy International Inc. Glaxosmithkline Plc Serta Simmons Bedding Llc

For more information about this report visit https://www.researchandmarkets.com/research/9hx3l4/sleeping_aids?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180808005628/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Medical Devices,Central Nervous System Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/08/2018 01:52 PM/DISC: 08/08/2018 01:52 PM

http://www.businesswire.com/news/home/20180808005628/en

AP RADIO
Update hourly